Natalizumab: Solution concentrate for I.V. infusion 300 mg in 15 mL; Tysabri® Page last updated: 1 November 2019 Public Summary Document (PSD) July 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) July 2019 PBAC Meeting - (Word 181KB)